CLINCAL AND FUNCTIONAL EFFECTS OF BETA-BLOCKER THERAPY DISCONTINUATION IN PATIENTS WITH BIVENTRICULAR HEART FAILURE (DESTRO: DECIDERE EVENTUALE SOSPENSIONE TERAPIA RECETTORIALE OTTIMIZZATA)
Anno:
2023
Background: Nearly two-third of patients with heart failure with reduced ejection fraction (HFrEF) have right ventricular (RV) dysfunction, which has previously been identified as an independent predictor of reduced functional capacity and poor prognosis. However, RV has received little attention in the past. Beta-blocker therapy (β-BT) has been shown to…